Jasvinder A Singh1,2, Michelle M Dowsey3,4, Michael Dohm3,4, Susan M Goodman3,4, Amye L Leong3,4, Marieke M J H Scholte Voshaar3,4, Peter F Choong3,4. 1. From the University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; Department of Orthopedics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; University of Melbourne Department of Surgery, St. Vincent's Hospital, Melbourne, Australia; Department of Orthopedic Surgery and Department of Medicine, University of Arizona, Tucson, Arizona; Weill Cornell Medical School and Hospital for Special Surgery, New York, New York; Healthy Motivation, and Global Alliance for Musculoskeletal Health, the Bone and Joint Decade, Santa Barbara, California, USA; Department of Psychology, Health and Technology, University of Twente, Enschede, the Netherlands. Jasvinder.md@gmail.com. 2. J.A. Singh, MBBS, MPH, Professor of Medicine and Epidemiology, University of Alabama at Birmingham and Staff Physician, Birmingham Veterans Affairs Medical Center, and Research Collaborator, Department of Orthopedics, Mayo Clinic College of Medicine; M.M. Dowsey, PhD, National Health and Medical Research Council Clinical Research Fellow, University of Melbourne Department of Surgery, St. Vincent's Hospital; M. Dohm, MD, Assistant Professor, Department of Orthopedic Surgery and Department of Medicine, University of Arizona; S.M. Goodman, MD, Associate Professor of Clinical Medicine, Weill Cornell Medical School and Associate Attending Hospital for Special Surgery; A.L. Leong, MBA, President and CEO, Healthy Motivation, and Director of Strategic Relations, Global Alliance for Musculoskeletal Health, the Bone and Joint Decade; M.M. Scholte Voshaar, PhD, Research Fellow, Department of Psychology, Health and Technology, University of Twente; P.F. Choong, MBBS, MD, FRACS, FAOrthA Professor of Surgery, University of Melbourne, and Head of Department of Surgery, and Director of Orthopedic Surgery, St. Vincent's Hospital. Jasvinder.md@gmail.com. 3. From the University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; Department of Orthopedics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; University of Melbourne Department of Surgery, St. Vincent's Hospital, Melbourne, Australia; Department of Orthopedic Surgery and Department of Medicine, University of Arizona, Tucson, Arizona; Weill Cornell Medical School and Hospital for Special Surgery, New York, New York; Healthy Motivation, and Global Alliance for Musculoskeletal Health, the Bone and Joint Decade, Santa Barbara, California, USA; Department of Psychology, Health and Technology, University of Twente, Enschede, the Netherlands. 4. J.A. Singh, MBBS, MPH, Professor of Medicine and Epidemiology, University of Alabama at Birmingham and Staff Physician, Birmingham Veterans Affairs Medical Center, and Research Collaborator, Department of Orthopedics, Mayo Clinic College of Medicine; M.M. Dowsey, PhD, National Health and Medical Research Council Clinical Research Fellow, University of Melbourne Department of Surgery, St. Vincent's Hospital; M. Dohm, MD, Assistant Professor, Department of Orthopedic Surgery and Department of Medicine, University of Arizona; S.M. Goodman, MD, Associate Professor of Clinical Medicine, Weill Cornell Medical School and Associate Attending Hospital for Special Surgery; A.L. Leong, MBA, President and CEO, Healthy Motivation, and Director of Strategic Relations, Global Alliance for Musculoskeletal Health, the Bone and Joint Decade; M.M. Scholte Voshaar, PhD, Research Fellow, Department of Psychology, Health and Technology, University of Twente; P.F. Choong, MBBS, MD, FRACS, FAOrthA Professor of Surgery, University of Melbourne, and Head of Department of Surgery, and Director of Orthopedic Surgery, St. Vincent's Hospital.
Abstract
OBJECTIVE: Discussion and endorsement of the OMERACT total joint replacement (TJR) core domain set for total hip replacement (THR) and total knee replacement (TKR) for endstage arthritis; and next steps for selection of instruments. METHODS: The OMERACT TJR working group met at the 2016 meeting at Whistler, British Columbia, Canada. We summarized the previous systematic reviews, the preliminary OMERACT TJR core domain set and results from previous surveys. We discussed preliminary core domains for TJR clinical trials, made modifications, and identified challenges with domain measurement. RESULTS: Working group participants (n = 26) reviewed, clarified, and endorsed each of the inner and middle circle domains and added a range of motion domain to the research agenda. TJR were limited to THR and TKR but included all endstage hip and knee arthritis refractory to medical treatment. Participants overwhelmingly endorsed identification and evaluation of top instruments mapping to the core domains (100%) and use of subscales of validated multidimensional instruments to measure core domains for the TJR clinical trial core measurement set (92%). CONCLUSION: An OMERACT core domain set for hip/knee TJR trials has been defined and we are selecting instruments to develop the TJR clinical trial core measurement set to serve as a common foundation for harmonizing measures in TJR clinical trials.
OBJECTIVE: Discussion and endorsement of the OMERACT total joint replacement (TJR) core domain set for total hip replacement (THR) and total knee replacement (TKR) for endstage arthritis; and next steps for selection of instruments. METHODS: The OMERACT TJR working group met at the 2016 meeting at Whistler, British Columbia, Canada. We summarized the previous systematic reviews, the preliminary OMERACT TJR core domain set and results from previous surveys. We discussed preliminary core domains for TJR clinical trials, made modifications, and identified challenges with domain measurement. RESULTS: Working group participants (n = 26) reviewed, clarified, and endorsed each of the inner and middle circle domains and added a range of motion domain to the research agenda. TJR were limited to THR and TKR but included all endstage hip and knee arthritis refractory to medical treatment. Participants overwhelmingly endorsed identification and evaluation of top instruments mapping to the core domains (100%) and use of subscales of validated multidimensional instruments to measure core domains for the TJR clinical trial core measurement set (92%). CONCLUSION: An OMERACT core domain set for hip/knee TJR trials has been defined and we are selecting instruments to develop the TJR clinical trial core measurement set to serve as a common foundation for harmonizing measures in TJR clinical trials.
Authors: Susan M Goodman; Bella Y Mehta; Lisa A Mandl; Jackie D Szymonifka; Jackie Finik; Mark P Figgie; Iris Y Navarro-Millán; Mathias P Bostrom; Michael L Parks; Douglas E Padgett; Alexander S McLawhorn; Vinicius C Antao; Adolph J Yates; Bryan D Springer; Stephen L Lyman; Jasvinder A Singh Journal: J Arthroplasty Date: 2019-12-27 Impact factor: 4.757
Authors: Anh Hoang; Susan M Goodman; Iris Y Navarro-Millán; Lisa A Mandl; Mark P Figgie; Mathias P Bostrom; Douglas E Padgett; Peter K Sculco; Alexander S McLawhorn; Jasvinder A Singh Journal: Arthritis Res Ther Date: 2017-12-06 Impact factor: 5.156
Authors: Robert Prill; Jasvinder A Singh; Gesine H Seeber; Sabrina Mai Nielsen; Susan Goodman; Sven Michel; Christian Kopkow; Robert Schulz; Peter Choong; Hagen Hommel Journal: BMJ Open Date: 2020-06-28 Impact factor: 2.692
Authors: R R van Tol; E van Zwietering; J Kleijnen; J Melenhorst; L P S Stassen; C D Dirksen; S O Breukink Journal: Int J Colorectal Dis Date: 2018-04-22 Impact factor: 2.571
Authors: Pieter Coenen; Gerben Hulsegge; Joost G Daams; Rutger C van Geenen; Gino M Kerkhoffs; Maurits W van Tulder; Judith A Huirne; Johannes R Anema; P Paul Kuijer Journal: BMJ Open Sport Exerc Med Date: 2020-03-26
Authors: U Plenge; M B Nortje; L C Marais; J D Jordaan; R Parker; N van der Westhuizen; J F van der Merwe; J Marais; W V September; G L Davies; T Pretorius; C Solomon; P Ryan; A M Torborg; Z Farina; R Smit; C Cairns; H Shanahan; S Sombili; A Mazibuko; H R Hobbs; O S Porrill; N E Timothy; R E Siebritz; C van der Westhuizen; A J Troskie; C A Blake; L A Gray; T W Munting; H K S Steinhaus; P Rowe; J G van der Walt; R Isaacs Noordien; A Theron; B M Biccard Journal: BMC Musculoskelet Disord Date: 2018-05-09 Impact factor: 2.362
Authors: Malou E M Te Molder; José M H Smolders; Petra J C Heesterbeek; Cornelia H M van den Ende Journal: BMC Musculoskelet Disord Date: 2020-06-13 Impact factor: 2.362